Qube Research & Technologies (QRT)
CAMP icon

Qube Research & Technologies (QRT)’s CAMP4 Therapeutics CAMP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,803
Closed -$109K – 3510
2026
Q1 		$109K Buy
+24,803
New +$118K ﹤0.01% 3057
2025
Q3 		– Sell
-14,871
Closed -$21.6K – 3595
2025
Q2 		$21.6K Buy
+14,871
New +$29.6K ﹤0.01% 3251

Other funds holding CAMP

Jupiter Topco
Jupiter Topco New York $245B AUM
5AM Venture Management
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
AH Capital Management
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Trails Edge Capital Partners
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT)'s CAMP Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of CAMP4 Therapeutics (CAMP) in Q2 2026, closing a stake of 24,803 shares — an estimated $109K sold.

Qube Research & Technologies (QRT) first reported a position in CAMP in Q2 2025 and held it in 2 quarters. The position peaked at $109K in Q1 2026. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining CAMP4 Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 24,803 CAMP4 Therapeutics shares in Q2 2026, an estimated $109K.
  • Qube Research & Technologies (QRT) first reported a position in CAMP4 Therapeutics in Q2 2025 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s CAMP4 Therapeutics position peaked at $109K in Q1 2026.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.